Asensus Surgical Inc. (ASXC): Price and Financial Metrics
ASXC Price/Volume Stats
| Current price | $0.25 | 52-week high | $0.74 |
| Prev. close | $0.25 | 52-week low | $0.20 |
| Day low | $0.25 | Volume | 872,271 |
| Day high | $0.26 | Avg. volume | 1,541,914 |
| 50-day MA | $0.28 | Dividend yield | N/A |
| 200-day MA | $0.30 | Market Cap | 68.05M |
ASXC Stock Price Chart Interactive Chart >
Asensus Surgical Inc. (ASXC) Company Bio
Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, economic shortcomings in surgery. The Senhance Surgical System features as the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world while staying true to the principles of value-based healthcare. The company was founded by William N. Starling in 2006 and is headquartered in Morrisville, NC.
Latest ASXC News From Around the Web
Below are the latest news stories about ASENSUS SURGICAL INC that investors may wish to consider to help them evaluate ASXC as an investment opportunity.
Asensus Announces Sale of Senhance Robotic System in RomaniaSenhance® System to be placed at a pediatric hospital in Timisoara, Romania Senhance Surgical System The Senhance Surgical System was developed to address the challenges of pediatric surgery while preserving the benefits of minimally invasive surgery. RESEARCH TRIANGLE PARK, N.C., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient, announced the sale of a Senhance® Surgical Syst |
3 Stocks at the Forefront of Medical RoboticsEvery now and then, speculation – within carefully defined limits – may be appropriate, which brings us to the case for medical robotics stocks to buy. |
Senhance Robotic System Sold by Asensus SurgicalSenhance® System to be placed at a hospital in the Commonwealth of Independent States Senhance Surgical System The Senhance Surgical System is the only commercially available robotic surgery system with haptic feedback, a differentiating feature for surgeons. RESEARCH TRIANGLE PARK, N.C., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company digitizing the interface between the surgeon and patient, announced that a Senhance® Surgical System has |
Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2023RESEARCH TRIANGLE PARK, N.C., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the third quarter 2023. Recent Highlights 17% growth in surgical procedures, with over 2,700 procedures performed globally year to date at September 30, 2023Two Senhance Surgical programs |
Asensus Surgical Announces Sale of Senhance Robotic SystemSenhance® System to be placed at a pediatric hospital in the Commonwealth of Independent States Senhance Robotic System A Senhance Surgical System will be placed in a pediatric hospital in the Commonwealth of Independent States (CIS) region. RESEARCH TRIANGLE PARK, N.C., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company digitizing the interface between the surgeon and the patient, announced that a Senhance® Surgical System was sold to the Co |
ASXC Price Returns
| 1-mo | 4.12% |
| 3-mo | -12.77% |
| 6-mo | 11.91% |
| 1-year | -63.24% |
| 3-year | -86.77% |
| 5-year | -99.02% |
| YTD | -21.61% |
| 2023 | -8.12% |
| 2022 | -68.73% |
| 2021 | 77.60% |
| 2020 | -57.48% |
| 2019 | -95.00% |
Loading social stream, please wait...